SPDR SP Valuation
| XPH Etf | USD 43.73 0.25 0.57% |
At this time, the etf appears to be fairly valued. SPDR SP Pharmaceuticals has a current Real Value of $44.14 per share. The regular price of the etf is $43.73. Our model measures the value of SPDR SP Pharmaceuticals from examining the etf fundamentals such as number of employees of 12, and Price To Earning of 6.56 X as well as evaluating its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that SPDR SP's price fluctuation is very steady at this time. Calculation of the real value of SPDR SP Pharmaceuticals is based on 3 months time horizon. Increasing SPDR SP's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SPDR SP is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SPDR Etf. However, SPDR SP's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 43.73 | Real 44.14 | Hype 43.73 |
The intrinsic value of SPDR SP's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence SPDR SP's stock price.
Estimating the potential upside or downside of SPDR SP Pharmaceuticals helps investors to forecast how SPDR etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SPDR SP more accurately as focusing exclusively on SPDR SP's fundamentals will not take into account other important factors: SPDR SP Total Value Analysis
SPDR SP Pharmaceuticals is at this time projected to have company total value of 236.07 M with market capitalization of 236.07 M, debt of , and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the SPDR SP fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
236.07 M | 236.07 M |
SPDR SP Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of SPDR signifies not a very effective usage of assets in January.About SPDR SP Valuation
An absolute valuation paradigm, as applied to SPDR Etf, attempts to find the value of SPDR SP Pharmaceuticals based on its fundamental and basic technical indicators. By analyzing SPDR SP's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of SPDR SP's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of SPDR SP. We calculate exposure to SPDR SP's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SPDR SP's related companies. When determining whether SPDR SP Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Pharmaceuticals Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Pharmaceuticals Etf:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Pharmaceuticals. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.